Zobel, M. J., Zamora, A. K., Wu, H., Sun, J., Lascano, D., Malvar, J., . . . Kim, E. S. (2020). Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice. J Immunother Cancer.
Citação norma ChicagoZobel, Michael John, et al. "Initiation of Immunotherapy With Activated Natural Killer Cells and Anti-GD2 Antibody Dinutuximab Prior to Resection of Primary Neuroblastoma Prolongs Survival in Mice." J Immunother Cancer 2020.
Citação norma MLAZobel, Michael John, et al. "Initiation of Immunotherapy With Activated Natural Killer Cells and Anti-GD2 Antibody Dinutuximab Prior to Resection of Primary Neuroblastoma Prolongs Survival in Mice." J Immunother Cancer 2020.